Skip to main content
Clinical Trials/KCT0009639
KCT0009639
Recruiting
未知

Compare the Safety, Efficacy, and Opioid Consumption of Maxigesic and Paracetamol for Pain Control in the Recovery Room Following Maxillofacial Surgery

Seoul National University Dental Hospital0 sites72 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Symptoms, signs and abnormal clinical and laboratory findings, NEC
Sponsor
Seoul National University Dental Hospital
Enrollment
72
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • ? Patients aged 19 to 60 years old
  • ? Patients who are American Society of Anesthesiologists physical status I or II
  • ? Patients who are scheduled for double jaw surgery
  • ? Patients with body mass index (BMI) between 18\.5 and 30 kg/m2

Exclusion Criteria

  • ? Patients with hypersensitivity or allergy to NSAIDs, opioids, acetaminophen
  • ? Patients taking medications that may affect clinical trial results, such as pain relievers, sedatives, and psychiatric medications
  • ? Patients who are pregnant or breastfeeding
  • ? Patients with liver, kidney or brain dysfunction
  • ? Contraindications to NSAIDs or paracetamol, such as previous gastric ulcer, heart failure, renal failure, thrombocytopenia, liver dysfunction, asthma, nasal polyps, hypersensitivity to the drug, and patients taking heavy alcohol.
  • ? Patients for whom VAS evaluation is expected to be impossible
  • ? Patient with pain before surgery
  • ? Patients weighing less than 50 kg
  • ? Other patients determined by the investigator to be excluded

Outcomes

Primary Outcomes

Not specified

Similar Trials